Assetmark, Inc Axonics, Inc. Transaction History

Assetmark, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$66.47 - $69.65 $598 - $626	9 New	9 $0
Q2 2023 Aug 11, 2023	BUY	$47.99 - $60.21 $110,520 - $138,663	2,303 Added 3.95%	60,535 $3.06 Million
Q1 2023 May 05, 2023	SELL	$52.6 - $67.34 $309,708 - $396,497	-5,888 Reduced 9.18%	58,232 $3.18 Million
Q4 2022 Feb 10, 2023	SELL	$59.56 - $76.6 $627,881 - $807,517	-10,542 Reduced 14.12%	64,120 $4.01 Million
Q3 2022 Nov 01, 2022	BUY	$57.96 - $78.12 $176,488 - $237,875	3,045 Added 4.25%	74,662 $5.26 Million
Q2 2022 Aug 03, 2022	BUY	$39.5 - $64.42 $493,987 - $805,636	12,506 Added 21.16%	71,617 $4.06 Million
Q1 2022 May 13, 2022	BUY	$43.74 - $62.76 $1.23 Million - $1.76 Million	28,009 Added 90.06%	59,111 $3.7 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $1.48 Million - $2.17 Million	29,531 Added 1879.76%	31,102 $1.74 Million
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $93,018 - $123,574	1,571 New	1,571 $102,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.